Gradalis, Inc.
Dallas, TX
- UEI
- SLKUWPLJJTF2
- CAGE
- 47HY3
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 8333 Douglas Ave #1600, Dallas, TX 75225, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir phase i award | National Cancer Institute (NIH) | $199,938 | |
| Anti-stathmin bifunctional small hairpin RNA: preclinical development of high potency, low toxicity GMP DNA - phase i… | National Cancer Institute (NIH) | $199,045 |
Quick answers
Is Gradalis, Inc. registered in SAM.gov?
Yes. Gradalis, Inc.'s SAM.gov registration is active through July 6, 2027.
What is Gradalis, Inc.'s most recent federal award?
Gradalis, Inc.'s most recent federal contract award is Sbir phase i award (HHSN261201100055C), from National Cancer Institute (NIH), on September 27, 2011.
On GovTribe
See Gradalis, Inc.'s full federal record
- Federal contract awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors